NFE2/Nrf2 repression
2017-06-02T16:27:16
2017-06-02T16:27:16
NFE2/Nrf2 repression
NFE2/Nrf2 repression
Molecular
2017-06-02T16:27:39
2017-06-02T16:27:39
Increased, steatosis
Increased, steatosis
Organ
2017-06-02T16:28:19
2017-06-02T16:28:19
Reduced, FXR activity
Reduced, FXR activity
Molecular
2017-06-02T16:29:13
2017-06-02T16:29:13
Reduced, SHP activity
Reduced, SHP activity
Molecular
2017-06-02T16:30:54
2017-06-02T16:30:54
Activated, LXR
Activated, LXR
Molecular
2017-06-02T16:31:25
2017-06-02T16:31:25
Reduced, PPARalpha
Reduced, PPARalpha
Molecular
2017-06-02T16:32:03
2017-06-02T16:32:03
Reduced, HSD17B4 activity
Reduced, HSD17B4 activity
Molecular
2017-06-02T16:32:45
2017-06-02T16:32:45
Reduced, fatty acid beta oxidation
Reduced, fatty acid beta oxidation
Molecular
2017-06-02T16:35:30
2017-06-02T16:35:30
77ca056a-fe92-4a5f-aef8-c7aa2f6022e8
6bff3441-d63a-4eae-99a9-408dd5ed3b3e
2017-06-02T16:35:50
2017-06-02T16:35:50
6bff3441-d63a-4eae-99a9-408dd5ed3b3e
9620d7c2-3137-4f0b-af31-401537d2acee
2017-06-02T16:36:04
2017-06-02T16:36:04
9620d7c2-3137-4f0b-af31-401537d2acee
8b85e9f9-5fe1-4961-a816-0c3aa5b4aca2
2017-06-02T16:36:22
2017-06-02T16:36:22
8b85e9f9-5fe1-4961-a816-0c3aa5b4aca2
4b18e1ed-c175-4cb0-8a07-5d33db14162f
2017-06-02T16:36:37
2017-06-02T16:36:37
4b18e1ed-c175-4cb0-8a07-5d33db14162f
d76ebae7-9673-4e21-8454-064f84481d00
2017-06-02T16:36:51
2017-06-02T16:36:51
d76ebae7-9673-4e21-8454-064f84481d00
8743afed-0b8f-4f95-9c3a-f3c00326dd0f
2017-06-02T16:37:13
2017-06-02T16:37:13
8743afed-0b8f-4f95-9c3a-f3c00326dd0f
596f5284-4359-414c-a823-cf6334bc30bc
2017-06-02T16:37:26
2017-06-02T16:37:26
NFE2/Nrf2 repression to steatosis
NFE2/Nrf2 repression to steatosis
Open for adoption
Under Development
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
adjacent
Not Specified
Not Specified
Not Specified
2017-06-02T16:26:43
2023-04-29T13:02:15